Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001830755-25-000005

Chief Medical Officer sold 10,000 shares at $20.00 ($200,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hamilton James C · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-13 Sale : show line 1 in the form 10b5-1 −611 $20.00 $12,220 271,511 D
2025-08-15 Sale : show line 2 in the form 10b5-1 −9,389 $20.00 $187,780 262,122 D
Open-market sales · 10,000 sh · avg $20.00 · $200,000
Loading xslF345X05/wk-form4_1755295139.xml…